Public-registry site landscape for NCT05284617, a Heart Failure With Preserved Ejection Fraction study sponsored by Rivus Pharmaceuticals, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05284617 (registry record) |
| Sponsor | Rivus Pharmaceuticals, Inc. |
| Condition(s) | Heart Failure With Preserved Ejection Fraction |
| Phase | PHASE2 |
| Listed sites | 15 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05284617 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →